APETx4

General Information


DRACP ID  DRACP02004

Peptide Name   APETx4

Sequence  GTTCYCGKTIGIYWFGKYSCPTNRGYTGSCPYFLGICCYPVD

Sequence Length  42

UniProt ID  C0HL40 

PubChem CID  Not available

Origin  Anthopleura elegantissima (Green aggregating anemone) (Actinia elegantissima)

Type  Native peptide

Classification

  

Active ACP KV10.1 inhibitor



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MDA-MB-435S Amelanotic melanoma Carcinoma KV10.1 Expression Level: Moderate CellTox Green Dye assay Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  NIH-3T3: KV10.1 Expression Level (Undetectable); Human epithelial cell line hTERT RPE-1: KV10.1 Expression Level (Moderate)

Target  Not available

Affinity  Not available

Mechanism  APETx4 is able to selectively inhibit the human ether-à-go-go channel (hEag1 or KV10.1), which a cancer-relevant voltage-gated potassium channel that is overexpressed in a majority of human tumors.

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02004

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C211H301N49O59S6

Absent amino acids  AEHMQ

Common amino acids  G

Mass  539185

Pl  8.1

Basic residues  3

Acidic residues  1

Hydrophobic residues  8

Net charge  2

Boman Index  -1560

Hydrophobicity  3.33

Aliphatic Index  44.05

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  14815

Absorbance 280nm  361.34

Polar residues  27

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28902151

Title  APETx4, a Novel Sea Anemone Toxin and a Modulator of the Cancer-Relevant Potassium Channel KV10.1

Doi 10.3390/md15090287

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.